This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Clauss, M. Articles by Schaper, W. Search for Related Content PubMed PubMed Citation Articles by Clauss, M. Articles by Schaper, W. Related Collections Angiogenesis Apoptosis Growth factors/cytokines Ischemic biology - basic studies Endothelium/vascular type/nitric oxide

(Circulation Research. 2000;86:251.)
© 2000 American Heart Association, Inc.

Editorials

Vascular Endothelial Growth Factor

A Jack-of-All-Trades or a Nonspecific Stress Gene?

Matthias Clauss, Wolfgang Schaper

From the Department of Molecular Cell Biology (M.C.), Max-Planck-Institute for Physiological and Clinical Research; Department of Experimental Cardiology (W.S.), Max-Planck-Institute for Physiological and Clinical Research, Bad Nauheim, Germany.

Correspondence to Wolfgang Schaper, MD, PhD, Max-Planck-Institute, Department of Experimental Cardiology, D-61231 Bad Nauheim, Germany. E-mail w.schaper@kerckhoff.mpg.de

Key Words: growth factors • acidosis • endothelium

	Introduction

 
In this issue of Circulation Research, D’Arcangelo et al¹ report highly interesting and unexpected results in that acidosis inhibits proliferation and migration of cultured endothelial cells, inhibits the formation of capillary tubes, but simultaneously increases expression of the endothelial growth factors vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF)-2. In addition, VEGF expression was caused neither by hif-1 activation nor increased mRNA stability. In line with the latter observation may be that VEGF transgenic mice in which a reporter gene is controlled by the VEGF promoter missing the VEGF mRNA stabilizing downstream 3' sequences² still show expression in the periphery of tumors but restricted to non–tumor fibroblast-like cells.³

However, a word of caution should be permitted with regard to the interpretation of results. A 2-fold overexpression detected by a semiquantitative polymerase chain reaction method may not be extremely convincing, and the unorthodox mechanism of expression may be the result of simply no significant induction. Perhaps these findings may not have attracted so much attention were it not for the special relevance to tumor angiogenesis. In tumors, acidosis is the expected metabolic event, because most tumors prefer anaerobic glycolysis above the aerobic pathway even in the presence of oxygen, as we know from the pioneering work of Warburg et al.⁴ Another reason for acidosis in tumors is the hypoxia due to deficient capillarization.

The failing capillarization of growing tumors, which ultimately leads to a necrotic core, may have to do with the acidosis that apparently counteracts the hypoxic . . . [Full Text of this Article]

This article has been cited by other articles:

				W. D. Fox, B. Higgins, K. M. Maiese, M. Drobnjak, C. Cordon-Cardo, H. I. Scher, and D. B. Agus Antibody to Vascular Endothelial Growth Factor Slows Growth of an Androgen-independent Xenograft Model of Prostate Cancer Clin. Cancer Res., October 1, 2002; 8(10): 3226 - 3231. [Abstract] [Full Text] [PDF]

				J. C. Hershey, E. P. Baskin, J. D. Glass, H. A. Hartman, D. B. Gilberto, I. T. Rogers, and J. J. Cook Revascularization in the rabbit hindlimb: dissociation between capillary sprouting and arteriogenesis Cardiovasc Res, February 16, 2001; 49(3): 618 - 625. [Abstract] [Full Text] [PDF]